🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Retrospective Observational Study of Italian Cohort of Lymphoma Patients (RETRO-LYMPH)

Recruitingn/aAges 18 Years - anyAllIRCCS Azienda Ospedaliero-Universitaria di Bologna
NCT06781437 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

observational, non-interventional, retrospective, single-center study focusing on patients with lymphoma / lymphoproliferative syndrome between January 1980 and September 2021

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * Age greater than or equal to 18 years of enrollment * Diagnosis of lymphoma or lymphoproliferative syndrome between January 1980 and September 2021 * Signature of the informed consent form where applicable Exclusion Criteria: * none
💊

What it tests

  • Not listed
📍

Where

1 site
IRCCS Azienda Ospedaliero - Universitaria di Bologna
Bologna, Italy
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy